TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

4DMT Appoints Kristian Humer as Chief Financial Officer

GlobeNewswire Inc. Logo GlobeNewswire Inc. By 4D Molecular Therapeutics
4DMT Appoints Kristian Humer as Chief Financial Officer

4D Molecular Therapeutics announced the appointment of Kristian Humer as Chief Financial Officer, bringing over two decades of finance and biotechnology experience to support the company's late-stage clinical development and commercial planning.

Insights
FDMT   positive

Company is advancing multiple Phase 3 programs, preparing for commercial readiness, and hiring an experienced finance executive to support strategic growth